YAP1 and hepatocellular carcinoma: In addition, FR5 can reduce tumor growth in xenograft mouse models with hepatocellular carcinoma by coordinating the inhibition of YAP in the Hippo pathway, demonstrating FR5 as a potential therapeutic option for this cancer.